# Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; establishment of a public docket; request for comments; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a notice entitled “Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the *Federal Register* of April 11, 2023. The document announced a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Lisa Granger, Office of Policy, Planning, Legislation and International Affairs, Food and Drug Administration, 301-796-9115, *[email protected].*
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of Tuesday, April 11, 2023 (88 FR 21688) in FR Doc. 2023-248, the following corrections are made:
1. On page 21688, in the third column, in the header of the document, “Docket No. FDA-2023-N-0378” is corrected to read “Docket No. FDA-2023-N-1338” and in the *ADDRESSES* section, in the third line of the last paragraph, “FDA-2023-N-0378” is corrected to read “FDA-2023-N-1338.”
2. On page 21689, in the first column, in the second line of the “Instructions:” section, Docket No. FDA-2023-N-0378” is corrected to read “Docket No. FDA-2023-N-1338”.
Dated: April 14, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.